A

Arrivent Biopharma Inc
NASDAQ:AVBP

Watchlist Manager
Arrivent Biopharma Inc
NASDAQ:AVBP
Watchlist
Price: 21.97 USD -1.44% Market Closed
Market Cap: 906.9m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of AVBP.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AVBP Intrinsic Value
Not Available
Base Case Scenario
Compare AVBP to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AVBP?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Arrivent Biopharma Inc

Current Assets 321.2m
Cash & Short-Term Investments 300.3m
Receivables 505k
Other Current Assets 20.4m
Non-Current Assets 5.3m
Long-Term Investments 5.1m
PP&E 49k
Other Non-Current Assets 180k
Current Liabilities 21.6m
Accounts Payable 5.9m
Accrued Liabilities 15.6m
Efficiency

Free Cash Flow Analysis
Arrivent Biopharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Arrivent Biopharma Inc

Revenue
0 USD
Operating Expenses
-162.4m USD
Operating Income
-162.4m USD
Other Expenses
11m USD
Net Income
-151.4m USD
Fundamental Scores

AVBP Profitability Score
Profitability Due Diligence

Arrivent Biopharma Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Negative ROE
hidden
Profitability
Score

Arrivent Biopharma Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

AVBP Solvency Score
Solvency Due Diligence

Arrivent Biopharma Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Arrivent Biopharma Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AVBP Price Targets Summary
Arrivent Biopharma Inc

Wall Street analysts forecast AVBP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AVBP is 41.57 USD with a low forecast of 31.31 USD and a high forecast of 49.35 USD.

Lowest
Price Target
31.31 USD
43% Upside
Average
Price Target
41.57 USD
89% Upside
Highest
Price Target
49.35 USD
125% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Arrivent Biopharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AVBP is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y